Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Oncology field"'
Autor:
Beltrán Hernández, Irati, Kromhout, Jannes Z, Teske, Erik, Hennink, Wim E, van Nimwegen, Sebastiaan A, Oliveira, Sabrina, Afd Pharmaceutics, Interne geneeskunde GD, dCSCA AVR, Chirurgie, Sub Cell Biology, Pharmaceutics, Celbiologie, CS_Cancer
Publikováno v:
Theranostics
Theranostics, 11(8), 3882. Ivyspring International Publisher
Theranostics, 11(8), 3882. Ivyspring International Publisher
Despite clinical successes in the treatment of some early stage cancers, it is undeniable that novel and innovative approaches are needed to aid in the fight against cancer. Targeted therapies offer the desirable feature of tumor specificity while sp
Publikováno v:
International Journal of Novel Trends in Pharmaceutical Sciences. 10:83-86
Today, bio-clinical endeavours are incoming the subcellular level, which is seen with the quick creating grounds of nanomedicine, nanodiagnostics and nano therapy related to the execution of nanoparticles for ailment counteraction, analysis, treatmen
Publikováno v:
Nanomedicine. 15:1861-1871
Glioblastoma multiforme is a serious medical issue in the brain oncology field due to its aggressiveness and recurrence. Immunotherapy has emerged as a valid approach to counteract the growth and metastasization of glioblastoma multiforme. Among the
Autor:
Marianne Pearson, Laura Melton
Publikováno v:
Oncology Issues. 35:46-51
Distress is a common experience in people with cancer and is recognized by the psychosocial oncology field as an important experience to explore with patients. Patients with cancer in general have ...
Publikováno v:
Advanced Drug Delivery Reviews. 158:140-157
Nanoparticles can provide effective control of the release rate and tissue distribution of their drug payload, leading to major pharmacokinetic and pharmacodynamic changes vis-à-vis the conventional administration of free drugs. In the last two deca
Autor:
Nicolas Magné, Wafa Bouleftour
Publikováno v:
Aging clinical and experimental research. 34(4)
Aging is a universal complex and multifactorial physiological process that leads to the increasing incidence of various diseases including cancer. Indeed, 40% of individuals aged 65 years and over will have newly diagnosed cancers. Although most trea
Publikováno v:
Journal of Advanced Research in Dynamical and Control Systems. 11:76-85
Autor:
Andrea Ferrari, Filippo Spreafico, Patrizia Gasparini, Raffaella Sensi, Marco Chisari, Elisabetta Schiavello, Fulvia Angela Gariboldi, Carlo Alfredo Clerici, Veronica Biassoni, Augusto Caraceni, Maura Massimino
Publikováno v:
Tumori Journal. 105:NP75-NP78
This study reports a case series of patients with upper limb neuromotor deficits following pediatric central nervous system tumor and treated with rehabilitative therapy according to action observation therapy (AOT). AOT is based on the “mirror neu
Autor:
Oum Kaltoum Ait Boujmia
Publikováno v:
Naunyn-Schmiedeberg's archives of pharmacology. 394(6)
V-domain Ig suppressor of T cell activation (VISTA) is a transmembrane protein that plays a crucial role in the regulation of antitumor immunity. Therapeutic intervention that inhibits the VISTA pathway constitutes a new approach in the treatment of
Autor:
Stefanos Theoharis
Publikováno v:
Journal of pharmaceutical sciences. 110(5)
The advent and rapid propagation of Chimeric Antigen Receptor (CAR)-based therapeutics in recent years has taken the oncology field by storm and delivered considerable benefit to cancer patients, many of whom previously had no other treatment options